Alfredo Darmanin-Sheehan

Title: The Innovative Contributions of Alfredo Darmanin-Sheehan

Introduction

Alfredo Darmanin-Sheehan is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of therapeutic target identification, particularly through his work with Variable New Antigen Receptor (VNAR) domains. His innovative approach has the potential to impact medical treatments significantly.

Latest Patents

Darmanin-Sheehan holds a patent for the "Isolation of therapeutic target specific VNAR domains to ICOSL." This invention provides ICOSL specific antigen binding molecules that are isolated from immunized and synthetic Elasmobranchii derived libraries. The patent focuses on shark VNAR domains that specifically bind and neutralize the activity of human Induced Co-Stimulatory Ligand (ICOSL). The neutralizing VNAR domains are derived from two independent sources: an immunized nurse shark library and a synthetic spiny dogfish framework fusion library. These molecules can be formulated as pharmaceutical compositions for medical use.

Career Highlights

Throughout his career, Alfredo Darmanin-Sheehan has worked with esteemed institutions such as the University of Aberdeen and Elasmogen Limited. His work has been pivotal in advancing the understanding of VNAR domains and their applications in medicine.

Collaborations

Darmanin-Sheehan has collaborated with notable professionals in his field, including William James Jonathan Finlay and Caroline Barelle. These collaborations have further enriched his research and development efforts.

Conclusion

Alfredo Darmanin-Sheehan's innovative work in the field of therapeutic targets showcases his dedication to advancing medical science. His contributions, particularly through his patent on VNAR domains, highlight the potential for new treatments in medicine.